Funding history
- $95M2026-08-14Source: news.google.com ↗
More Health companies
Recently funded startups in the same category.
Khartis is a biopharmaceutical company focused on developing innovative oral therapies. The company aims to provide effective alternatives to existing treatments, specifically targeting conditions treated by Tepezza. This funding round will support their efforts in advancing their oral challenger to Tepezza.
Recently funded startups in the same category.